financetom
Business
financetom
/
Business
/
--Americold Realty Trust Keeps Quarterly Dividend at $0.22 a Share, Payable Oct. 15 to Shareholders of Record on Sept. 30
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Americold Realty Trust Keeps Quarterly Dividend at $0.22 a Share, Payable Oct. 15 to Shareholders of Record on Sept. 30
Sep 3, 2024 9:03 AM

11:25 AM EDT, 09/03/2024 (MT Newswires) --

Price: 28.89, Change: -0.11, Percent Change: -0.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Roblox Lifts 2025 Bookings Outlook, Flags Margin Pressures Amid Higher Spending
Roblox Lifts 2025 Bookings Outlook, Flags Margin Pressures Amid Higher Spending
Oct 30, 2025
02:05 PM EDT, 10/30/2025 (MT Newswires) -- Roblox ( RBLX ) raised its full-year bookings guidance, while the video game platform flagged potential margin pressures from increased investments in infrastructure and people. For fiscal 2025, the company now expects bookings of $6.57 billion to $6.62 billion, representing growth of 50% to 51% year over year, up from its prior outlook...
AstraZeneca Gefurulimab Shows Positive Phase 3 Results in Myasthenia Gravis Trial
AstraZeneca Gefurulimab Shows Positive Phase 3 Results in Myasthenia Gravis Trial
Oct 30, 2025
02:01 PM EDT, 10/30/2025 (MT Newswires) -- AstraZeneca ( AZN ) reported positive results from its Phase 3 trial of gefurulimab, showing statistically significant and clinically meaningful improvements in patients' ability to perform daily activities with generalized Myasthenia Gravis, a chronic autoimmune neuromuscular disorder. The trial met its primary endpoint, demonstrating a significant improvement in the Myasthenia Gravis Activities of...
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy
Oct 30, 2025
02:10 PM EDT, 10/30/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Thursday its autologous gene therapy Zevaskyn received a permanent Healthcare Common Procedure Coding System J-code from the Centers for Medicare and Medicaid Services. The new product-specific identifier, J3389 - Topical administration, prademagene zamikeracel, per treatment - will take effect on Jan. 1, 2026, the company added. Zevaskyn...
--Louisiana-Pacific Keeps Quarterly Dividend at $0.28 a Share, Payable Nov. 21 to Holders of Record Nov. 14
--Louisiana-Pacific Keeps Quarterly Dividend at $0.28 a Share, Payable Nov. 21 to Holders of Record Nov. 14
Oct 30, 2025
02:10 PM EDT, 10/30/2025 (MT Newswires) -- Price: 89.32, Change: +0.23, Percent Change: +0.26 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved